Form 8-K

Arena Pharmaceuticals (ARNA)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Dec 5, 2017)8-K (Nov 7, 2017)8-K (Aug 7, 2017)8-K (Jul 13, 2017)8-K (Jul 11, 2017)8-K (Jul 10, 2017)8-K (Jun 15, 2017)8-K (May 9, 2017)8-K (Apr 18, 2017)8-K (Apr 17, 2017)8-K (Mar 14, 2017)8-K (Feb 14, 2017)8-K (Jan 6, 2017)8-K (Jan 4, 2017)8-K (Nov 7, 2016)8-K (Oct 3, 2016)8-K (Sep 1, 2016)8-K (Aug 25, 2016)8-K (Aug 15, 2016)8-K (Aug 8, 2016)8-K (Jul 19, 2016)8-K (Jun 30, 2016)8-K (Jun 13, 2016)8-K (Jun 10, 2016)8-K (May 9, 2016)8-K (Apr 12, 2016)8-K (Mar 21, 2016)8-K (Feb 29, 2016)8-K (Jan 12, 2016)8-K (Dec 1, 2015)8-K (Nov 10, 2015)8-K (Oct 29, 2015)8-K (Oct 27, 2015)8-K (Oct 5, 2015)8-K (Aug 5, 2015)8-K (Jul 29, 2015)8-K (Jul 9, 2015)8-K (Jun 16, 2015)8-K (May 11, 2015)8-K (Apr 30, 2015)8-K (Apr 10, 2015)8-K (Mar 3, 2015)8-K (Mar 2, 2015)8-K (Feb 3, 2015)8-K (Jan 23, 2015)8-K (Jan 20, 2015)8-K (Jan 12, 2015)8-K (Jan 9, 2015)8-K (Dec 5, 2014)8-K (Nov 3, 2014)8-K (Oct 30, 2014)8-K (Oct 9, 2014)8-K (Aug 1, 2014)8-K (Jul 21, 2014)8-K (Jun 13, 2014)8-K (Jun 3, 2014)8-K (May 12, 2014)8-K (May 9, 2014)8-K (Mar 27, 2014)8-K (Feb 27, 2014)8-K (Feb 12, 2014)8-K (Feb 3, 2014)8-K (Jan 13, 2014)8-K (Nov 8, 2013)8-K (Nov 7, 2013)8-K (Oct 15, 2013)8-K (Aug 29, 2013)8-K (Aug 28, 2013)8-K (Aug 1, 2013)8-K (Jul 25, 2013)8-K (Jun 26, 2013)8-K (Jun 14, 2013)8-K (Jun 7, 2013)8-K (May 2, 2013)8-K (Apr 5, 2013)8-K (Apr 1, 2013)8-K (Mar 4, 2013)8-K (Feb 25, 2013)8-K (Jan 22, 2013)8-K (Dec 19, 2012)8-K (Nov 28, 2012)8-K (Nov 6, 2012)8-K (Oct 12, 2012)8-K (Aug 9, 2012)8-K (Jul 12, 2012)8-K (Jun 28, 2012)8-K (Jun 20, 2012)8-K (May 29, 2012)8-K (May 17, 2012)8-K (May 15, 2012)8-K (May 10, 2012)8-K (May 1, 2012)8-K (Mar 26, 2012)8-K (Mar 14, 2012)8-K (Mar 8, 2012)8-K (Mar 2, 2012)8-K (Feb 14, 2012)8-K (Feb 1, 2012)8-K (Jan 26, 2012)8-K (Jan 11, 2012)8-K (Jan 10, 2012)8-K (Jan 3, 2012)8-K (Dec 21, 2011)8-K (Nov 9, 2011)8-K (Nov 8, 2011)8-K (Oct 24, 2011)8-K (Oct 3, 2011)8-K (Sep 13, 2011)8-K (Aug 12, 2011)8-K (Aug 11, 2011)8-K (Aug 9, 2011)8-K (Aug 2, 2011)8-K (Jul 13, 2011)8-K (Jun 24, 2011)8-K (Jun 14, 2011)8-K (May 26, 2011)8-K (May 10, 2011)8-K (Mar 29, 2011)8-K (Mar 11, 2011)8-K (Mar 4, 2011)8-K (Feb 11, 2011)8-K (Jan 28, 2011)8-K (Jan 25, 2011)8-K (Dec 23, 2010)8-K (Dec 13, 2010)8-K (Nov 12, 2010)8-K (Nov 9, 2010)8-K (Nov 4, 2010)8-K (Oct 25, 2010)8-K (Oct 20, 2010)8-K (Sep 22, 2010)8-K (Sep 16, 2010)8-K (Aug 30, 2010)8-K (Aug 6, 2010)8-K (Aug 3, 2010)8-K (Jul 14, 2010)8-K (Jul 1, 2010)8-K (Jun 28, 2010)8-K (Jun 14, 2010)8-K (Jun 8, 2010)8-K (Jun 2, 2010)8-K (May 7, 2010)8-K (Mar 24, 2010)8-K (Mar 12, 2010)8-K (Mar 8, 2010)8-K (Feb 26, 2010)8-K (Feb 24, 2010)8-K (Jan 27, 2010)8-K (Dec 23, 2009)8-K (Dec 11, 2009)8-K (Nov 10, 2009)8-K (Oct 30, 2009)8-K (Oct 21, 2009)8-K (Sep 18, 2009)8-K (Aug 3, 2009)8-K (Jul 9, 2009)8-K (Jul 8, 2009)8-K (Jul 6, 2009)8-K (Jul 1, 2009)8-K (Jun 23, 2009)8-K (Jun 8, 2009)8-K (May 11, 2009)8-K (Apr 23, 2009)8-K (Apr 14, 2009)8-K (Mar 30, 2009)8-K (Mar 23, 2009)8-K (Mar 12, 2009)8-K (Feb 26, 2009)8-K (Feb 18, 2009)8-K (Jan 29, 2009)8-K (Dec 31, 2008)8-K (Dec 16, 2008)8-K (Dec 9, 2008)8-K (Nov 26, 2008)8-K (Oct 30, 2008)8-K (Oct 28, 2008)8-K (Aug 15, 2008)8-K (Aug 5, 2008)8-K (Jul 9, 2008)8-K (May 7, 2008)8-K (Apr 8, 2008)8-K (Mar 17, 2008)8-K (Feb 27, 2008)8-K (Jan 30, 2008)8-K (Jan 25, 2008)8-K (Jan 10, 2008)8-K (Jan 8, 2008)8-K (Dec 20, 2007)8-K (Dec 13, 2007)8-K (Dec 12, 2007)8-K (Nov 2, 2007)8-K (Oct 17, 2007)8-K (Oct 4, 2007)8-K (Sep 25, 2007)8-K (Sep 11, 2007)8-K (Jul 19, 2007)8-K (Jul 18, 2007)8-K (Jun 18, 2007)8-K (May 8, 2007)8-K (Apr 18, 2007)8-K (Apr 13, 2007)8-K (Mar 27, 2007)8-K (Mar 5, 2007)8-K (Mar 1, 2007)8-K (Feb 21, 2007)8-K (Feb 13, 2007)8-K (Feb 7, 2007)8-K (Jan 26, 2007)8-K (Dec 19, 2006)8-K (Dec 8, 2006)8-K (Nov 16, 2006)8-K (Oct 25, 2006)8-K (Sep 27, 2006)8-K (Sep 25, 2006)8-K (Sep 12, 2006)8-K (Aug 14, 2006)8-K (Aug 1, 2006)8-K (Jul 25, 2006)8-K (Jul 6, 2006)8-K (Jun 16, 2006)8-K (Jun 13, 2006)8-K (May 18, 2006)8-K (May 8, 2006)8-K (Apr 19, 2006)8-K (Mar 29, 2006)8-K (Mar 20, 2006)8-K (Feb 22, 2006)8-K (Feb 3, 2006)8-K (Jan 27, 2006)8-K (Jan 24, 2006)8-K (Dec 30, 2005)8-K (Dec 21, 2005)8-K (Dec 13, 2005)8-K (Oct 17, 2005)8-K (Oct 11, 2005)8-K (Aug 26, 2005)8-K (Jul 19, 2005)8-K (Jun 30, 2005)8-K (Jun 7, 2005)8-K (May 11, 2005)8-K (May 5, 2005)8-K (Apr 26, 2005)8-K (Apr 25, 2005)8-K (Feb 17, 2005)8-K (Feb 9, 2005)8-K (Feb 1, 2005)8-K (Jan 21, 2005)8-K (Jan 13, 2005)8-K (Dec 23, 2004)8-K (Dec 1, 2004)8-K (Oct 26, 2004)8-K (Oct 20, 2004)8-K (Sep 15, 2004)8-K (Aug 10, 2004)8-K (Jul 20, 2004)8-K (Jul 14, 2004)8-K (Jun 14, 2004)8-K (Jun 8, 2004)8-K (Apr 21, 2004)8-K (Mar 17, 2004)8-K (Jan 20, 2004)8-K (Jan 6, 2004)8-K (Dec 30, 2003)8-K (Dec 17, 2003)8-K (Oct 22, 2003)8-K (Aug 12, 2003)8-K (Apr 23, 2003)8-K (Jan 21, 2003)8-K (Nov 1, 2002)8-K (Oct 17, 2002)8-K (Mar 11, 2002)8-K (Apr 30, 2001)8-K (Mar 26, 2001)8-K (Feb 21, 2001)

Other

Arena Pharmaceuticals 8-K 2010

Documents found in this filing:

Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 9, 2010

Arena Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

Delaware

000-31161

23-2908305

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

6166 Nancy Ridge Drive, San Diego, California 92121

(Address of principal executive offices) (Zip Code)

858.453.7200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

In this report, “Arena Pharmaceuticals,” “Arena,” “we,” “us” and “our” refer to Arena Pharmaceuticals, Inc., unless the context otherwise provides.

Item 2.02 Results of Operations and Financial Condition.

On November 9, 2010, we issued a press release reporting our financial results for the third quarter ended September 30, 2010. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits.


99.1		Press release issued November 9, 2010, reporting financial results for the third quarter ended September 30, 2010

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: November 9, 2010	Arena Pharmaceuticals, Inc.

	By:	/s/ Steven W. Spector
		Steven W. Spector
		Senior Vice President, General Counsel and
		Secretary

EXHIBIT INDEX


Exhibit No.		Description

99.1		Press release issued November 9, 2010, reporting financial results for the third quarter ended September 30, 2010

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Arena Pharmaceuticals (ARNA)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: